fda warning letters compounded semaglutide tirzepatide september 2025 issued 25 to telehealth companies for false and misleading claims about GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Beyond the Headlines: FDA Warning

Understanding which classes are generally lower-risk versus those requiring provider consultation helps guide informed symptom-relief decisions during acute illness

Weill Professor of Metabolic Research and director of the Comprehensive Weight Control Center at Weill Cornell Medicine, said of the study's findings, which he described as "not a surprise." Aronne noted that the body naturally releases seven to eight hormones when food is consumed in order to provide a sense of fullness

Most SSRIs can generally be used with tirzepatide without direct interaction, with shared nausea being the main overlap

After two weeks, all except amiloride demonstrated a significant reduction in ICP ranging from 10.3% to 14.5%, with no significant superiority of one drug over another